Delivery of chemotherapy for testicular cancer in routine practice: A population-based study.
CONCLUSIONS: Almost half of patients treated with BEP/EP chemotherapy in routine practice have some form of reduced chemotherapy delivery. Despite this, long-term survival in the general population is very high. Further studies are required to understand the extent to which dose delivery might influence outcomes.
PMID: 30478011 [PubMed - as supplied by publisher]
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Karim S, Wei X, Leveridge MJ, Siemens DR, Robinson AG, Bedard PL, Booth CM Tags: Urol Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Germ Cell Tumors | Seminoma | Study | Testicular Cancer | Urology & Nephrology